It is widely believed that protection against acquisition of HIV or SIV infection requires anti-envelope (anti-Env) antibodies, and that cellular immunity may affect viral loads but not acquisition, except in special cases. Here we provide evidence to the contrary. Mucosal immunization may enhance HIV vaccine efficacy by eliciting protective responses at portals of exposure. Accordingly, we vaccinated macaques mucosally with HIV/SIV peptides, modified vaccinia Ankara–SIV (MVA-SIV), and HIV-gp120–CD4 fusion protein plus adjuvants, which consistently reduced infection risk against heterologous intrarectal SHIVSF162P4 challenge, both high dose and repeated low dose. Surprisingly, vaccinated animals exhibited no anti-gp120 humoral responses above background and Gag- and Env-specific T cells were induced but failed to correlate with viral acquisition. Instead, vaccine-induced gut microbiome alteration and myeloid cell accumulation in colorectal mucosa correlated with protection. Ex vivo stimulation of the myeloid cell–enriched population with SHIV led to enhanced production of trained immunity markers TNF-α and IL-6, as well as viral coreceptor agonist MIP1α, which correlated with reduced viral Gag expression and in vivo viral acquisition. Overall, our results suggest mechanisms involving trained innate mucosal immunity together with antigen-specific T cells, and also indicate that vaccines can have critical effects on the gut microbiome, which in turn can affect resistance to infection. Strategies to elicit similar responses may be considered for vaccine designs to achieve optimal protective efficacy.
Yongjun Sui, George K. Lewis, Yichuan Wang, Kurt Berckmueller, Blake Frey, Amiran Dzutsev, Diego Vargas-Inchaustegui, Venkatramanan Mohanram, Thomas Musich, Xiaoying Shen, Anthony DeVico, Timothy Fouts, David Venzon, James Kirk, Robert C. Waters, James Talton, Dennis Klinman, John Clements, Georgia D. Tomaras, Genoveffa Franchini, Marjorie Robert-Guroff, Giorgio Trinchieri, Robert C. Gallo, Jay A. Berzofsky
Title and authors | Publication | Year |
---|---|---|
Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge
Chege GK, Chapman RE, Keyser AT, Adams CH, Benn K, van Diepen MT, Douglass N, Lambson B, Hermanus T, Moore PL, Williamson AL |
Viruses | 2025 |
Innate protection against intrarectal SIV acquisition by a live SHIV vaccine.
Sui Y, Meyer TJ, Fennessey CM, Keele BF, Dadkhah K, Ma C, LaBranche CC, Breed MW, Kramer JA, Li J, Howe SE, Ferrari G, Williams LD, Cam M, Kelly MC, Shen X, Tomaras GD, Montefiori D, Greten TF, Miller CJ, Berzofsky JA |
JCI insight | 2024 |
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response
Rahman MA, Bissa M, Scinto H, Howe SE, Sarkis S, Ma ZM, Gutowska A, Jiang X, Luo CC, Schifanella L, Moles R, Silva de Castro I, Basu S, N\u2019guessan KF, Williams LD, Becerra-Flores M, Doster MN, Hoang T, Choo-Wosoba H, Woode E, Sui Y, Tomaras GD, Paquin-Proulx D, Rao M, Talton JD, Kong XP, Zolla-Pazner S, Cardozo T, Franchini G, Berzofsky JA |
Nature Communications | 2024 |
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications
Capriotti Z, Klase Z |
Journal of Neurovirology | 2024 |
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy
Sui Y, Andersen H, Li J, Hoang T, Minai M, Nagata BM, Bock KW, Alves DA, Lewis MG, Berzofsky JA |
Vaccine | 2023 |
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
S Lakhashe, M Amacker, D Hariraju, H Vyas, K Morrison, J Weiner, M Ackerman, V Roy, G Alter, G Ferrari, D Montefiori, G Tomaras, S Sawant, N Yates, C Gast, S Fleury, R Ruprecht |
Frontiers in immunology | 2022 |
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
A Borgognone, M Noguera-Julian, B Oriol, L Noël-Romas, M Ruiz-Riol, Y Guillén, M Parera, M Casadellà, C Duran, M Puertas, F Català-Moll, M Leon, S Knodel, K Birse, C Manzardo, J Miró, B Clotet, J Martinez-Picado, J Moltó, B Mothe, A Burgener, C Brander, R Paredes, S Benet, C Brander, S Cedeño, B Clotet, P Coll, A Llano, J Martinez-Picado, M Marszalek, S Morón-López, B Mothe, R Paredes, M Puertas, M Rosás-Umbert, M Ruiz-Riol, R Escrig, S Gel, M López, C Miranda, J Moltó, J Muñoz, N Perez-Alvarez, J Puig, B Revollo, J Toro, A Barriocanal, C Perez-Reche, M Farré, M Valle, C Manzardo, J Ambrosioni, I Ruiz, C Rovira, C Hurtado, C Ligero, E Fernández, S Sánchez-Palomino, J Miró, A Carrillo, M Meulbroek, F Pujol, J Saz, N Borthwick, A Crook, E Wee, T Hanke |
Microbiome | 2022 |
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses
P Klasse, J Moore, G Silvestri |
Journal of virology | 2022 |
Trained Immunity and HIV Infection
Sviridov D, Miller YI, Bukrinsky MI |
Frontiers in immunology | 2022 |
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques
Sui Y, Li J, Andersen H, Zhang R, Prabhu SK, Hoang T, Venzon D, Cook A, Brown R, Teow E, Velasco J, Pessaint L, Moore IN, Lagenaur L, Talton J, Breed MW, Kramer J, Bock KW, Minai M, Nagata BM, Choo-Wosoba H, Lewis MG, Wang LX, Berzofsky JA |
2022 | |
Myeloid-derived suppressor cells and vaccination against pathogens
Prochetto E, Borgna E, Jiménez-Cortegana C, Sánchez-Margalet V, Cabrera G |
Frontiers in Cellular and Infection Microbiology | 2022 |
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
Yongjun Sui, Jianping Li, Roushu Zhang, Sunaina K. Prabhu, Hanne Andersen Elyard, David Venzon, Anthony Cook, Renita Elizabeth Brown, Jason Velasco, Elyse Teow, Jack Greenhouse, Tammy Putmon-Taylor, Tracey-Ann V Campbell, Laurent Pessaint, Ian Moore, Laurel A. Lagenaur, James D. Talton, Matthew W Breed, Joshua Kramer, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Mark G. Lewis, Lai-Xi Wang, Jay A. Berzofsky |
JCI Insight | 2021 |
Microbiome Studies in Non-human Primates
JM Brenchley, AM Ortiz |
Current HIV/AIDS Reports | 2021 |
SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage
Y Sui, J Li, DJ Venzon, JA Berzofsky |
Frontiers in immunology | 2021 |
Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-Like Particles Induces Strong Mucosal Immune Responses against HIV
D Liu, S Zhang, E Poteet, C Marin-Muller, C Chen, Q Yao |
Human vaccines | 2021 |
Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
ME Ottogalli, PE Rodríguez, MC Frutos, LB Moreno, LM Ghietto, CG Cuffini, JA Cámara, MP Adamo, LE Valinotto, A Cámara |
Archives of Virology | 2021 |
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial
JV Chua, C Davis, JS Husson, A Nelson, I Prado, R Flinko, KW Lam, L Mutumbi, BT Mayer, D Dong, W Fulp, C Mahoney, M Gerber, R Gottardo, BL Gilliam, K Greene, H Gao, N Yates, G Ferrari, G Tomaras, D Montefiori, JA Schwartz, T Fouts, AL DeVico, GK Lewis, RC Gallo, MM Sajadi |
Vaccine | 2021 |
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine–Induced Anti-V2 Antibodies Alone
AJ Hessell, L Li, DC Malherbe, P Barnette, S Pandey, W Sutton, D Spencer, XH Wang, JS Gach, R Hunegnaw, M Tuen, X Jiang, CC Luo, CC LaBranche, Y Shao, DC Montefiori, DN Forthal, R Duerr, M Robert-Guroff, NL Haigwood, MK Gorny |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus
Anca Dorhoi, Leigh A. Kotze, Jay A. Berzofsky, Yongjun Sui, Dmitry I. Gabrilovich, Ankita Garg, Richard Hafner, Shabaana A. Khader, Ulrich E. Schaible, Stefan H.E. Kaufmann, Gerhard Walzl, Manfred B. Lutz, Robert N. Mahon, Suzanne Ostrand-Rosenberg, William R. Bishai, Nelita du Plessis |
Journal of Clinical Investigation | 2020 |
HIV vaccines: Unmasking myeloid derived suppressor cells
WR Green, MA O'Connor |
EBioMedicine | 2020 |
Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development
Y Sui, JA Berzofsky |
Frontiers in immunology | 2020 |
Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
ST Pasco, J Anguita |
Cells | 2020 |
Search for antiviral functions of potentially protective antibodies against V2 region of HIV-1
MK Gorny |
Human Vaccines & Immunotherapeutics | 2020 |
Does Mucosal B1 Activation Result in the Accumulation of Peak IgM During Chronic Intrarectal SIVmac239 Exposure to Protect Chinese-Origin Rhesus Macaques From Disease Progression?
Z Cong, L Tong, Y Wang, A Su, T Chen, Q Wei, J Xue, C Qin |
Frontiers in microbiology | 2020 |
A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques
T Musich, V Thovarai, DJ Venzon, V Mohanram, I Tuero, LK Miller-Novak, SH Hait, MA Rahman, R Hunegnaw, E Huiting, W Yuan, C OhUigin, T Hoang, Y Sui, C LaBranche, D Montefiori, J Bear, M Rosati, M Bissa, JA Berzofsky, GN Pavlakis, BK Felber, G Franchini, M Robert-Guroff, G Silvestri |
Journal of virology | 2020 |
Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1:
S Pittala, KS Morrison, ME Ackerman |
Current Opinion in HIV and AIDS | 2019 |
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination
JA Cram, AJ Fiore-Gartland, S Srinivasan, S Karuna, G Pantaleo, GD Tomaras, DN Fredricks, JG Kublin, E Morgan |
PloS one | 2019 |